Publication | Closed Access

Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure

Hematological MalignancyMyelodysplastic SyndromeMedicineAcute Myeloid LeukemiaAzanucleoside FailureHematologyMyeloid NeoplasiaMixed-phenotype Acute LeukemiaPharmacotherapyOncologyRadiation OncologyAplastic AnemiaHealth Sciences